2.19BMarket Cap-2.32P/E (TTM)
22.110High20.140Low1.23MVolume20.140Open19.840Pre Close26.19MTurnover1.45%Turnover RatioLossP/E (Static)102.06MShares55.70052wk High5.18P/B1.82BFloat Cap15.79052wk Low--Dividend TTM84.66MShs Float152.560Historical High--Div YieldTTM9.93%Amplitude7.100Historical Low21.267Avg Price1Lot Size
Biohaven Stock Forum
Biohaven Announces Investment up to $600 Million by Oberland Capital
Biohaven (NYSE: BHVN) has secured a significant non-dilutive investment of up to $600 million from Oberland Capital Management The deal structure includes:
- $250 million to be funded at closing by April 30, 2025
- $150 million available upon achieving regulatory milestones for troriluzole
- Up to $200 million by mutual agreement for strategic acquisitions
The investment, structured as a Note Purchase Ag...
Biohaven's Next-Gen Neuroscience Pipeline: 13 Groundbreaking Studies Target Parkinson's and Migraine
Biohaven's Troriluzole Stuns with 70% SCA Progression Slowdown - FDA Priority Review Granted
Biohaven Achieves Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia (SCA)
• Troriluzole 200 mg dosed orally, once daily, in patients with SCA met the study's primary endpoint on the change from baseline in the modified functional Scale for the Assessment and Rating of Ataxia (f-SARA) at 3 years in all study population genotypes.
◦ Troriluzole also showed statistically significant superiority after both 1 and 2 years of treatment.
• Tror...
RBC upgrades Estee Lauder $Estee Lauder (EL.US)$ to outperform from sector perform
RBC said it sees an attractive risk/reward.
“We are upgrading EL shares to Outperform. At this point, we believe EPS and investor sentiment have troughed and believe the risk-to-reward profile skews favorable.”
Morgan Stanley reiterates Tesla $Tesla (TSLA.US)$ as overweight
Morgan Sta...
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$